Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158246 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Xinjie He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. Hauptthemen laut MEDLINE: Coumarins, Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Committee, Shanghai ShenKang Hospital Development Center.
Abstract (Originalsprache)
Recent studies confirmed that pyroptosis is involved in the progression of pulmonary hypertension (PH), which could promote pulmonary artery remodeling. Urolithin A (UA), an intestinal flora metabolite of ellagitannins (ETs) and ellagic acid (EA), has been proven to possess inhibitory effects on pyroptosis under various pathological conditions. However, its role on PH remained undetermined. To investigate the potential of UA in mitigating PH, mice were exposed to hypoxia (10% oxygen, 4 weeks) to induce PH, with or without UA treatment. Moreover, in vitro experiments were carried out to further uncover the underlying mechanisms. The in vivo treatment of UA suppressed the progression of PH via alleviating pulmonary remodeling. Pyroptosis-related genes were markedly upregulated in mice models of PH and reversed after the administration of UA. In accordance with that, UA treatment significantly inhibited hypoxia-induced pulmonary arterial smooth muscle cell (PASMC) pyroptosis via the AMPK/NF-κB/NLRP3 pathway. Our results revealed that UA treatment effectively mitigated PH progression through inhibiting PASMC pyroptosis, which represents an innovative therapeutic approach for PH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Department of Cardiology, Punan Branch of Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200125, China.
ORCID-Profile: Wenyi Xu
Förderung
- National Natural Science Foundation of China
- Shanghai Science and Technology Committee
- Shanghai ShenKang Hospital Development Center
Zitieren
APA
He, X., Wu, Z., Jiang, J., Xu, W., Yuan, A., Liao, F., Ding, S., & Pu, J. (2024). Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158246
Vancouver
He X, Wu Z, Jiang J, Xu W, Yuan A, Liao F, et al. Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158246
BibTeX
@article{He2024,
author = {He, Xinjie and Wu, Zhinan and Jiang, Jinyao and Xu, Wenyi and Yuan, Ancai and Liao, Fei and Ding, Song and Pu, Jun},
title = {Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158246}
}
EUVIMED